Silva, Ingrid Laise Vivas 1. Merrill RM, Hunter BD. Seroprevalence of markers for hepatitis B viral infection. Int J Infect Diss. 2011 Feb;15(2):e78-121. 2. Wu CC, Chen YS, Cao L, Chen XW, Lu MJ. Hepatitis B virus infection: Defective surface antigen expression and pathogenesis. World J Gastroenterol. 2018 Ago;24(31):3488-99. 3. Lamontagne RJ, Bagga S, Bouchard MJ. Hepatitis B virus molecular biology and pathogenesis. Hepatoma Res 2016;2:163-86. 4. Dias JA, Cerutti Júnior C, Falqueto A. Fatores associados à infecção pelo vírus da hepatite B: um estudo caso-controle no município de São Mateus, Espírito Santo. Epidemiol Serv Saúde. 2014 dez;23(4):683-90. doi: https://doi.org/10.5123/S1679-49742014000400010 5. Rapti I, Hadziyannis S. Risk for hepatocellular carcinoma in the course of chronic hepatitis B virus infection and the protective effect of therapy with nucleos(t)ide analogues. World J Hepatol. 2015 May;7(8):1064-73. 6. Sohn W, Cho JY, Kim JH, Lee JI....
,
2023
